LY2886721: Precision BACE1 Inhibition and the Frontier of...
2025-10-21
Explore how LY2886721, a potent oral BACE inhibitor, enables nuanced modulation of amyloid beta while preserving synaptic function—advancing Alzheimer’s disease research beyond standard paradigms and offering new insight into neurodegenerative disease models.